SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'NOS'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_A_DCFA353_1 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | HIS A 70HIS A 219GLU A 222HIS A 256ASP A 307 | NoneNOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.38A | 1a4lA-4f0sA:21.5 | 1a4lA-4f0sA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_A_DCFA353_1 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | HIS A 72HIS A 219GLU A 222HIS A 256ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.51A | 1a4lA-4f0sA:21.5 | 1a4lA-4f0sA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_B_DCFB853_1 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 72LEU A 91HIS A 219GLU A 222HIS A 256ASP A 307 | NOS A 501 (-3.7A)NOS A 501 ( 4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.57A | 1a4lB-4f0sA:21.5 | 1a4lB-4f0sA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_C_DCFC1353_1 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 70HIS A 72HIS A 219GLU A 222HIS A 256ASP A 307 | NoneNOS A 501 (-3.7A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.47A | 1a4lC-4f0sA:21.5 | 1a4lC-4f0sA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4L_D_DCFD1853_1 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | HIS A 72HIS A 219GLU A 222HIS A 256ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.46A | 1a4lD-4f0sA:21.4 | 1a4lD-4f0sA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1D4F_C_ADNC603_2 (S-ADENOSYLHOMOCYSTEINE HYDROLASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 5 | THR A 196GLU A 226THR A 223LEU A 91 | NoneNoneNoneNOS A 501 ( 4.8A) | 1.15A | 1d4fC-4f0sA:undetectable | 1d4fC-4f0sA:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ITU_A_CILA451_1 (RENAL DIPEPTIDASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | HIS A 192HIS A 219HIS A 70ASN A 278ASP A 307 | NOS A 501 (-4.0A)NOS A 501 (-3.5A)NoneNoneNOS A 501 (-2.8A) | 1.29A | 1ituA-4f0sA:5.3 | 1ituA-4f0sA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JDV_A_ADNA1260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 10 | ARG A 88VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.44A | 1jdvA-2bsxA:31.91jdvD-2bsxA:31.9 | 1jdvA-2bsxA:29.301jdvD-2bsxA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JDV_B_ADNB2260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 10 | ARG A 88VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.42A | 1jdvB-2bsxA:32.01jdvC-2bsxA:31.8 | 1jdvB-2bsxA:29.301jdvC-2bsxA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JDV_D_ADND3260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 10 | ARG A 88VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.44A | 1jdvA-2bsxA:31.91jdvD-2bsxA:31.9 | 1jdvA-2bsxA:29.301jdvD-2bsxA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JDV_E_ADNE4260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 12 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.41A | 1jdvE-2bsxA:31.91jdvF-2bsxA:31.8 | 1jdvE-2bsxA:29.301jdvF-2bsxA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KYV_A_RBFA501_1 (6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | TRP A 96GLU A 99HIS A 219ILE A 95LEU A 91 | NOS A 501 ( 4.4A)NOS A 501 ( 2.8A)NOS A 501 (-3.5A)NOS A 501 (-4.2A)NOS A 501 ( 4.8A) | 1.14A | 1kyvA-4f0sA:undetectable1kyvE-4f0sA:undetectable | 1kyvA-4f0sA:16.291kyvE-4f0sA:16.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KYV_C_RBFC503_1 (6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | ILE A 95LEU A 91TRP A 96GLU A 99HIS A 219 | NOS A 501 (-4.2A)NOS A 501 ( 4.8A)NOS A 501 ( 4.4A)NOS A 501 ( 2.8A)NOS A 501 (-3.5A) | 1.14A | 1kyvB-4f0sA:undetectable1kyvC-4f0sA:undetectable | 1kyvB-4f0sA:16.291kyvC-4f0sA:16.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_A_ADNA1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 11 | ARG A 88GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.56A | 1odiA-2bsxA:25.0 | 1odiA-2bsxA:27.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_B_ADNB1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 11 | ARG A 88GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.53A | 1odiB-2bsxA:32.9 | 1odiB-2bsxA:27.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_C_ADNC1238_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 11 | ARG A 88GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.57A | 1odiC-2bsxA:33.4 | 1odiC-2bsxA:27.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_D_ADND1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 11 | ARG A 88GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.55A | 1odiD-2bsxA:33.3 | 1odiD-2bsxA:27.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_E_ADNE1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 11 | ARG A 88GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.53A | 1odiE-2bsxA:33.4 | 1odiE-2bsxA:27.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_F_ADNF1238_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 11 | ARG A 88GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.57A | 1odiF-2bsxA:33.3 | 1odiF-2bsxA:27.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK7_A_ADNA1245_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 9 | ARG A 88SER A 91GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.54A | 1pk7A-2bsxA:32.0 | 1pk7A-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK7_B_ADNB1246_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 8 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.48A | 1pk7B-2bsxA:32.3 | 1pk7B-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK7_C_ADNC1247_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 10 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.53A | 1pk7C-2bsxA:32.0 | 1pk7C-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK7_C_ADNC1247_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 10 | GLY A 93VAL A 181GLU A 182MET A 183ASP A 206 | NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-4.1A) | 1.35A | 1pk7C-2bsxA:32.0 | 1pk7C-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK9_A_2FAA306_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 10 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.52A | 1pk9A-2bsxA:31.9 | 1pk9A-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK9_B_2FAB307_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 9 | ARG A 88SER A 91GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.49A | 1pk9B-2bsxA:32.2 | 1pk9B-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK9_C_2FAC308_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 11 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.51A | 1pk9C-2bsxA:30.8 | 1pk9C-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PW7_A_RABA645_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 10 | ARG A 88SER A 91GLY A 93GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.53A | 1pw7A-2bsxA:31.9 | 1pw7A-2bsxA:28.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PW7_B_RABB646_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 9 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.53A | 1pw7B-2bsxA:32.2 | 1pw7B-2bsxA:28.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PW7_C_RABC647_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 9 | SER A 91VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 (-2.9A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.42A | 1pw7C-2bsxA:32.1 | 1pw7C-2bsxA:28.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_A_ADNA252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 11 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.64A | 1vhwA-2bsxA:32.41vhwD-2bsxA:32.5 | 1vhwA-2bsxA:29.171vhwD-2bsxA:29.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_B_ADNB252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 9 | ARG A 88SER A 91GLY A 93VAL A 181MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.64A | 1vhwB-2bsxA:32.01vhwF-2bsxA:32.2 | 1vhwB-2bsxA:29.171vhwF-2bsxA:29.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_C_ADNC252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 11 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.63A | 1vhwC-2bsxA:32.61vhwE-2bsxA:32.3 | 1vhwC-2bsxA:29.171vhwE-2bsxA:29.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_D_ADND252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 11 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.62A | 1vhwA-2bsxA:32.41vhwD-2bsxA:32.5 | 1vhwA-2bsxA:29.171vhwD-2bsxA:29.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_E_ADNE252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 11 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.63A | 1vhwC-2bsxA:32.61vhwE-2bsxA:32.3 | 1vhwC-2bsxA:29.171vhwE-2bsxA:29.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_F_ADNF252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 10 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.64A | 1vhwB-2bsxA:32.01vhwF-2bsxA:32.2 | 1vhwB-2bsxA:29.171vhwF-2bsxA:29.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z35_A_2FAA300_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 10 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.63A | 1z35A-2bsxA:33.2 | 1z35A-2bsxA:30.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z37_A_ADNA300_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 9 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.59A | 1z37A-2bsxA:33.3 | 1z37A-2bsxA:30.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A58_B_RBFB301_1 (6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | ILE A 95LEU A 91TRP A 96GLU A 99HIS A 219 | NOS A 501 (-4.2A)NOS A 501 ( 4.8A)NOS A 501 ( 4.4A)NOS A 501 ( 2.8A)NOS A 501 (-3.5A) | 1.11A | 2a58A-4f0sA:undetectable2a58B-4f0sA:undetectable | 2a58A-4f0sA:16.292a58B-4f0sA:16.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A58_C_RBFC302_1 (6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | ILE A 95LEU A 91TRP A 96GLU A 99HIS A 219 | NOS A 501 (-4.2A)NOS A 501 ( 4.8A)NOS A 501 ( 4.4A)NOS A 501 ( 2.8A)NOS A 501 (-3.5A) | 1.11A | 2a58B-4f0sA:undetectable2a58C-4f0sA:undetectable | 2a58B-4f0sA:16.292a58C-4f0sA:16.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A58_E_RBFE304_1 (6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | ILE A 95LEU A 91TRP A 96GLU A 99HIS A 219 | NOS A 501 (-4.2A)NOS A 501 ( 4.8A)NOS A 501 ( 4.4A)NOS A 501 ( 2.8A)NOS A 501 (-3.5A) | 1.11A | 2a58D-4f0sA:undetectable2a58E-4f0sA:undetectable | 2a58D-4f0sA:16.292a58E-4f0sA:16.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AC7_A_ADNA1216_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 11 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.56A | 2ac7A-2bsxA:31.72ac7B-2bsxA:31.8 | 2ac7A-2bsxA:29.712ac7B-2bsxA:29.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AC7_B_ADNB1215_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 11 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.56A | 2ac7A-2bsxA:31.72ac7B-2bsxA:31.8 | 2ac7A-2bsxA:29.712ac7B-2bsxA:29.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BR4_B_SAMB301_1 (CEPHALOSPORINHYDROXYLASE CMCI) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 4 | LEU A 91SER A 287ASP A 307ASP A 129 | NOS A 501 ( 4.8A)NoneNOS A 501 (-2.8A)None | 1.23A | 2br4B-4f0sA:undetectable | 2br4B-4f0sA:19.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DTT_E_H4BE1004_1 (HYPOTHETICAL PROTEINPH0634) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 11 | LEU A 285HIS A 219HIS A 72THR A 306GLU A 320 | NoneNOS A 501 (-3.5A)NOS A 501 (-3.7A)NoneNone | 1.33A | 2dttD-4f0sA:undetectable2dttE-4f0sA:undetectable | 2dttD-4f0sA:15.652dttE-4f0sA:15.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JIH_A_097A1001_1 (ADAMTS-1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 9 | ASP A 89THR A 223GLU A 222HIS A 219HIS A 192 | NoneNoneNOS A 501 (-3.0A)NOS A 501 (-3.5A)NOS A 501 (-4.0A) | 1.04A | 2jihA-4f0sA:undetectable | 2jihA-4f0sA:20.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JIH_B_097B1001_1 (ADAMTS-1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 8 | ASP A 89THR A 223GLU A 222HIS A 219HIS A 192 | NoneNoneNOS A 501 (-3.0A)NOS A 501 (-3.5A)NOS A 501 (-4.0A) | 1.04A | 2jihB-4f0sA:undetectable | 2jihB-4f0sA:20.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OW9_A_HAEA502_1 (COLLAGENASE 3) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 6 | LEU A 285HIS A 70HIS A 72HIS A 219 | NoneNoneNOS A 501 (-3.7A)NOS A 501 (-3.5A) | 0.86A | 2ow9A-4f0sA:undetectable | 2ow9A-4f0sA:15.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2PGR_A_DCFA501_1 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 70HIS A 72HIS A 219GLU A 222HIS A 256ASP A 307 | NoneNOS A 501 (-3.7A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.35A | 2pgrA-4f0sA:22.8 | 2pgrA-4f0sA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q0I_A_BEZA990_0 (QUINOLONE SIGNALRESPONSE PROTEIN) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 8 | ASP A 307HIS A 256SER A 287LEU A 285 | NOS A 501 (-2.8A)NOS A 501 (-4.0A)NoneNone | 0.93A | 2q0iA-4f0sA:undetectable | 2q0iA-4f0sA:22.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q0J_B_BEZB500_0 (QUINOLONE SIGNALRESPONSE PROTEIN) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 11 | ASP A 307HIS A 70HIS A 256SER A 287LEU A 285 | NOS A 501 (-2.8A)NoneNOS A 501 (-4.0A)NoneNone | 1.07A | 2q0jB-4f0sA:undetectable | 2q0jB-4f0sA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W0Q_A_CUA801_0 (COPPER AMINE OXIDASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 70HIS A 256HIS A 219 | NoneNOS A 501 (-4.0A)NOS A 501 (-3.5A) | 0.70A | 2w0qA-4f0sA:undetectable | 2w0qA-4f0sA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W0Q_B_CUB801_0 (COPPER AMINE OXIDASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 70HIS A 256HIS A 219 | NoneNOS A 501 (-4.0A)NOS A 501 (-3.5A) | 0.70A | 2w0qB-4f0sA:undetectable | 2w0qB-4f0sA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZXW_A_CUA517_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.77A | 2zxwA-4f0sA:undetectable | 2zxwA-4f0sA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ABK_A_CUA517_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.75A | 3abkA-4f0sA:undetectable | 3abkA-4f0sA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG2_A_CUA517_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.74A | 3ag2A-4f0sA:undetectable | 3ag2A-4f0sA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HII_A_CUA801_0 (AMILORIDE-SENSITIVEAMINE OXIDASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 70HIS A 256HIS A 219 | NoneNOS A 501 (-4.0A)NOS A 501 (-3.5A) | 0.71A | 3hiiA-4f0sA:undetectable | 3hiiA-4f0sA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HII_B_CUB801_0 (AMILORIDE-SENSITIVEAMINE OXIDASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 70HIS A 256HIS A 219 | NoneNOS A 501 (-4.0A)NOS A 501 (-3.5A) | 0.69A | 3hiiB-4f0sA:undetectable | 3hiiB-4f0sA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HY7_A_097A801_1 (A DISINTEGRIN ANDMETALLOPROTEINASEWITH THROMBOSPONDINMOTIFS 5) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 9 | ASP A 89THR A 223GLU A 222HIS A 219HIS A 192 | NoneNoneNOS A 501 (-3.0A)NOS A 501 (-3.5A)NOS A 501 (-4.0A) | 1.14A | 3hy7A-4f0sA:undetectable | 3hy7A-4f0sA:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HY7_B_097B801_1 (A DISINTEGRIN ANDMETALLOPROTEINASEWITH THROMBOSPONDINMOTIFS 5) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 9 | ASP A 89THR A 223GLU A 222HIS A 219HIS A 192 | NoneNoneNOS A 501 (-3.0A)NOS A 501 (-3.5A)NOS A 501 (-4.0A) | 1.23A | 3hy7B-4f0sA:undetectable | 3hy7B-4f0sA:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_B_VIAB901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 11 | HIS A 70ASN A 282LEU A 87LEU A 242THR A 223 | NoneNoneNOS A 501 (-4.8A)NoneNone | 1.35A | 3jwqB-4f0sA:undetectable3jwqC-4f0sA:undetectable | 3jwqB-4f0sA:21.123jwqC-4f0sA:21.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEC_A_HAEA272_1 (COLLAGENASE 3) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 5 | LEU A 285HIS A 70HIS A 72HIS A 219 | NoneNoneNOS A 501 (-3.7A)NOS A 501 (-3.5A) | 0.91A | 3kecA-4f0sA:undetectable | 3kecA-4f0sA:15.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_A_ADNA251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 9 | ARG A 88SER A 91VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.74A | 3u40A-2bsxA:31.43u40F-2bsxA:31.9 | 3u40A-2bsxA:28.293u40F-2bsxA:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_B_ADNB251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 10 | ARG A 88SER A 91VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.67A | 3u40B-2bsxA:31.13u40C-2bsxA:31.9 | 3u40B-2bsxA:28.293u40C-2bsxA:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_C_ADNC251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 12 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.56A | 3u40B-2bsxA:31.13u40C-2bsxA:31.9 | 3u40B-2bsxA:28.293u40C-2bsxA:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_D_ADND251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 11 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.55A | 3u40D-2bsxA:31.43u40E-2bsxA:31.2 | 3u40D-2bsxA:28.293u40E-2bsxA:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_E_ADNE251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 12 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.51A | 3u40D-2bsxA:31.43u40E-2bsxA:31.2 | 3u40D-2bsxA:28.293u40E-2bsxA:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_F_ADNF251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 10 | ARG A 88SER A 91VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.75A | 3u40A-2bsxA:31.43u40F-2bsxA:31.9 | 3u40A-2bsxA:28.293u40F-2bsxA:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_F_ADNF251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 10 | VAL A 181GLU A 182MET A 183GLU A 184ASP A 206 | NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A)NOS A1248 (-4.1A) | 1.09A | 3u40A-2bsxA:31.43u40F-2bsxA:31.9 | 3u40A-2bsxA:28.293u40F-2bsxA:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UAW_A_ADNA236_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 11 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.57A | 3uawA-2bsxA:32.3 | 3uawA-2bsxA:29.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UAY_A_ADNA236_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 10 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.55A | 3uayA-2bsxA:32.3 | 3uayA-2bsxA:29.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WDM_A_ADNA901_1 (4-PHOSPHOPANTOATE--BETA-ALANINE LIGASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 9 | ALA A 301ARG A 353GLY A 351LEU A 355ASN A 128 | NoneNOS A 502 (-4.4A)NoneNoneNone | 1.17A | 3wdmA-4f0sA:undetectable | 3wdmA-4f0sA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WDM_A_ADNA901_1 (4-PHOSPHOPANTOATE--BETA-ALANINE LIGASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 9 | ALA A 309ARG A 79GLY A 80LEU A 81ILE A 95 | NoneNoneNoneNoneNOS A 501 (-4.2A) | 1.46A | 3wdmA-4f0sA:undetectable | 3wdmA-4f0sA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WDM_D_ADND301_1 (4-PHOSPHOPANTOATE--BETA-ALANINE LIGASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 10 | ALA A 301ARG A 353GLY A 351LEU A 355ASN A 128 | NoneNOS A 502 (-4.4A)NoneNoneNone | 1.15A | 3wdmD-4f0sA:undetectable | 3wdmD-4f0sA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A7B_A_HAEA1273_1 (COLLAGENASE 3) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 6 | LEU A 285HIS A 70HIS A 72HIS A 219 | NoneNoneNOS A 501 (-3.7A)NOS A 501 (-3.5A) | 0.87A | 4a7bA-4f0sA:undetectable | 4a7bA-4f0sA:16.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AQL_A_TXCA1452_1 (GUANINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 7 / 12 | LEU A 87LEU A 91HIS A 219GLU A 222GLU A 226HIS A 256ASP A 307 | NOS A 501 (-4.8A)NOS A 501 ( 4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NoneNOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.78A | 4aqlA-4f0sA:46.9 | 4aqlA-4f0sA:26.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AQL_A_TXCA1452_1 (GUANINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | LEU A 91HIS A 219GLU A 222HIS A 256SER A 281ASP A 307 | NOS A 501 ( 4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NoneNOS A 501 (-2.8A) | 0.64A | 4aqlA-4f0sA:46.9 | 4aqlA-4f0sA:26.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D9H_A_ADNA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 11 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.55A | 4d9hA-2bsxA:31.7 | 4d9hA-2bsxA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DA6_A_GA2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 9 | SER A 91GLY A 93VAL A 181MET A 183GLU A 184 | NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.48A | 4da6A-2bsxA:31.2 | 4da6A-2bsxA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DA7_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 10 | ARG A 88GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.55A | 4da7A-2bsxA:31.3 | 4da7A-2bsxA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DAN_A_2FAA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 11 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.53A | 4danA-2bsxA:31.3 | 4danA-2bsxA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DAN_B_2FAB301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 7 / 12 | ARG A 88SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.59A | 4danA-2bsxA:31.34danB-2bsxA:31.4 | 4danA-2bsxA:23.814danB-2bsxA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R88_A_1LDA501_0 (CYTOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 72LEU A 87HIS A 219HIS A 256LEU A 285ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-4.8A)NOS A 501 (-3.5A)NOS A 501 (-4.0A)NoneNOS A 501 (-2.8A) | 0.60A | 4r88A-4f0sA:34.9 | 4r88A-4f0sA:25.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R88_B_1LDB501_0 (CYTOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 72LEU A 87HIS A 219GLU A 222LEU A 285ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NoneNOS A 501 (-2.8A) | 0.60A | 4r88B-4f0sA:35.7 | 4r88B-4f0sA:25.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R88_C_1LDC501_0 (CYTOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 72LEU A 87HIS A 219GLU A 222LEU A 285ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NoneNOS A 501 (-2.8A) | 0.62A | 4r88C-4f0sA:35.0 | 4r88C-4f0sA:25.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R88_D_1LDD501_0 (CYTOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 72LEU A 87HIS A 219GLU A 222LEU A 285ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NoneNOS A 501 (-2.8A) | 0.60A | 4r88D-4f0sA:35.0 | 4r88D-4f0sA:25.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R88_E_1LDE501_0 (CYTOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 72LEU A 87HIS A 219GLU A 222LEU A 285ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NoneNOS A 501 (-2.8A) | 0.61A | 4r88E-4f0sA:34.8 | 4r88E-4f0sA:25.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R88_F_1LDF502_0 (CYTOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 6 / 12 | HIS A 72LEU A 87HIS A 219GLU A 222LEU A 285ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NoneNOS A 501 (-2.8A) | 0.62A | 4r88F-4f0sA:35.1 | 4r88F-4f0sA:25.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5B3S_A_CUA603_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.74A | 5b3sA-4f0sA:undetectable | 5b3sA-4f0sA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5B3S_N_CUN603_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.75A | 5b3sN-4f0sA:undetectable | 5b3sN-4f0sA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3C_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 9 | ARG A 88SER A 91GLY A 93VAL A 181MET A 183GLU A 184 | NOS A1248 ( 4.5A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.54A | 5i3cA-2bsxA:32.4 | 5i3cA-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3C_B_AC2B301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 10 | SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.42A | 5i3cB-2bsxA:32.3 | 5i3cB-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3C_C_AC2C301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 6 / 11 | SER A 91GLY A 93VAL A 181GLU A 182MET A 183GLU A 184 | NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-3.1A) | 0.41A | 5i3cC-2bsxA:32.1 | 5i3cC-2bsxA:28.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MHW_A_CUA601_0 (LACCASE 2) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 4 | HIS A 72HIS A 256HIS A 219HIS A 70 | NOS A 501 (-3.7A)NOS A 501 (-4.0A)NOS A 501 (-3.5A)None | 1.02A | 5mhwA-4f0sA:undetectable | 5mhwA-4f0sA:23.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NEL_C_ACTC302_0 (PEPTIDOGLYCANN-ACETYLGLUCOSAMINEDEACETYLASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 6 | HIS A 72HIS A 70LEU A 91HIS A 192 | NOS A 501 (-3.7A)NoneNOS A 501 ( 4.8A)NOS A 501 (-4.0A) | 0.95A | 5nelB-4f0sA:4.75nelC-4f0sA:5.2 | 5nelB-4f0sA:19.595nelC-4f0sA:19.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X19_A_CUA603_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.73A | 5x19A-4f0sA:undetectable | 5x19A-4f0sA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X1B_A_CUA603_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.72A | 5x1bA-4f0sA:undetectable | 5x1bA-4f0sA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_A_HFGA1003_1 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | GLU A 99TRP A 90HIS A 72 | NOS A 501 ( 2.8A)NoneNOS A 501 (-3.7A) | 1.01A | 5xipA-4f0sA:undetectable | 5xipA-4f0sA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_A_HFGA1003_1 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | GLU A 222TRP A 90HIS A 192 | NOS A 501 (-3.0A)NoneNOS A 501 (-4.0A) | 0.94A | 5xipA-4f0sA:undetectable | 5xipA-4f0sA:21.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZNC_A_QI9A301_0 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 5 / 9 | VAL A 66GLY A 93VAL A 181GLU A 182ASP A 206 | NOS A1248 ( 3.8A)NOS A1248 (-4.0A)NOS A1248 ( 4.4A)NoneNOS A1248 (-4.1A) | 1.43A | 5zncA-2bsxA:42.8 | 5zncA-2bsxA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZNC_A_QI9A301_0 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 8 / 9 | VAL A 66SER A 91GLY A 93TYR A 160VAL A 181GLU A 182MET A 183TRP A 212 | NOS A1248 ( 3.8A)NOS A1248 (-2.9A)NOS A1248 (-4.0A)NOS A1248 (-4.7A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NOS A1248 (-4.6A) | 0.31A | 5zncA-2bsxA:42.8 | 5zncA-2bsxA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZNI_A_YMZA302_0 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
2bsx | PURINE NUCLEOSIDEPHOSPHORYLASE (Plasmodiumfalciparum) | 8 / 9 | VAL A 66GLY A 93TYR A 160VAL A 181GLU A 182MET A 183GLY A 207PRO A 209 | NOS A1248 ( 3.8A)NOS A1248 (-4.0A)NOS A1248 (-4.7A)NOS A1248 ( 4.4A)NoneNOS A1248 (-3.4A)NoneNOS A1248 ( 4.1A) | 0.46A | 5zniA-2bsxA:42.1 | 5zniA-2bsxA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6N7F_A_RBFA502_0 (PUTATIVE GLUTATHIONEREDUCTASE (GR)) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 4 / 7 | GLY A 356HIS A 217ASN A 128GLY A 303 | NOS A 502 (-3.6A)NoneNoneNone | 0.89A | 6n7fA-4f0sA:undetectable | 6n7fA-4f0sA:11.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6N91_A_DCFA401_0 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 7 / 12 | HIS A 72LEU A 87LEU A 91HIS A 219GLU A 222HIS A 256ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-4.8A)NOS A 501 ( 4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.67A | 6n91A-4f0sA:22.8 | 6n91A-4f0sA:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6N91_A_DCFA401_0 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | LEU A 87LEU A 91ALA A 193GLU A 222HIS A 256 | NOS A 501 (-4.8A)NOS A 501 ( 4.8A)NoneNOS A 501 (-3.0A)NOS A 501 (-4.0A) | 0.92A | 6n91A-4f0sA:22.8 | 6n91A-4f0sA:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6N91_B_DCFB401_0 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 7 / 12 | HIS A 72LEU A 87LEU A 91HIS A 219GLU A 222HIS A 256ASP A 307 | NOS A 501 (-3.7A)NOS A 501 (-4.8A)NOS A 501 ( 4.8A)NOS A 501 (-3.5A)NOS A 501 (-3.0A)NOS A 501 (-4.0A)NOS A 501 (-2.8A) | 0.76A | 6n91B-4f0sA:22.9 | 6n91B-4f0sA:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6N91_B_DCFB401_0 (ADENOSINE DEAMINASE) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 5 / 12 | LEU A 87LEU A 91ALA A 193GLU A 222HIS A 256 | NOS A 501 (-4.8A)NOS A 501 ( 4.8A)NoneNOS A 501 (-3.0A)NOS A 501 (-4.0A) | 0.91A | 6n91B-4f0sA:22.9 | 6n91B-4f0sA:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6NKN_A_CUA601_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.76A | 6nknA-4f0sA:undetectable | 6nknA-4f0sA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6NMF_A_CUA603_0 (CYTOCHROME C OXIDASESUBUNIT 1) |
4f0s | 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE DEAMINASE (Chromobacteriumviolaceum) | 3 / 3 | HIS A 219HIS A 70HIS A 256 | NOS A 501 (-3.5A)NoneNOS A 501 (-4.0A) | 0.73A | 6nmfA-4f0sA:undetectable | 6nmfA-4f0sA:21.89 |